COLORADO SPRINGS, Colo., Sept. 11 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced that it will present at the A.G. Edwards Growth Conference, which is being held September 18-19 at the New York Palace Hotel.
John G. Schulte, Spectranetics' president and chief executive officer, is scheduled to speak on Tuesday, September 18, at 9:30 a.m. Eastern time (7:30 a.m. Mountain time) and will discuss the Company's strategic initiatives, product pipeline and market opportunities.
Interested parties can access a live audio webcast and slide presentation at http://www.spectranetics.com. An archived presentation will be available on the Web site for 14 days.
Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company's disposable catheters use high-energy "cool" ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information visit http://www.spectranetics.com.
COMPANY CONTACT: INVESTOR & MEDIA CONTACTS:
Spectranetics Corporation Lippert/Heilshorn & Associates, Inc.
Guy Childs, Chief Financial Officer Bruce Voss or Don Markley
(719) 633-8333 (310) 691-7100
|SOURCE Spectranetics Corporation|
Copyright©2007 PR Newswire.
All rights reserved